Literature DB >> 15780513

Nicotinamide trials in diabetes intervention. Does a metabolite provide benefit?

Jacques Gosteli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15780513     DOI： 10.1016/j.mehy.2004.11.019

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN： 0306-9877            Impact factor:   1.538


× No keyword cloud information.
  2 in total

1.  NMR-based metabolomics of urine for the atherosclerotic mouse model using apolipoprotein-E deficient mice.

Authors:  Gregory C Leo; Andrew L Darrow
Journal:  Magn Reson Chem       Date:  2009-12       Impact factor: 2.447

2.  1-Methylnicotinamide (MNA), a primary metabolite of nicotinamide, exerts anti-thrombotic activity mediated by a cyclooxygenase-2/prostacyclin pathway.

Authors:  S Chlopicki; J Swies; A Mogielnicki; W Buczko; M Bartus; M Lomnicka; J Adamus; J Gebicki
Journal:  Br J Pharmacol       Date:  2007-07-16       Impact factor: 8.739
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.